Oncotarget-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2266161, encodeId=80bb226616106, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤科 经验分享：还有朋友是一样的吗，杂志接受了，支付了版面费，然后又被拒稿，而且没有明确原因拒稿，联系方式微：FFFWW101 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a59736045, createdName=ms4000001252060402, createdTime=Thu May 22 11:05:58 CST 2025, time=2025-05-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1214905, encodeId=b7c812149054d, content=这本不是已经被踢了？怎么还有****, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue Apr 26 23:15:23 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580262, encodeId=e88358026202, content=有钱的医院营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, beContent=营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801382, encodeId=0ed1801382ca, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：医学综合期刊 经验分享：再想起死复生基本不可能了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 21:57:40 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010960, encodeId=44fc1010960d8, content=偏重的研究方向：肿瘤 经验分享：2021年的文章都被pubmed收录了，我估计离复活不远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c06b1686709, createdName=飞翔的蜗牛, createdTime=Tue Aug 24 14:41:39 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105116, encodeId=26a611051165b, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105115, encodeId=dee31105115ae, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051245, encodeId=6487105124531, content=我感觉文章质量比同为水刊的plos one差太多了，尤其是最近几期太烂了。我认为回归的可能不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Tue Sep 14 19:59:27 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590707, encodeId=eca0590e0725, content=您好，不知道近期是否有晋升发表文章的需求？公司完稿文章论著数篇，无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了无奈的科研者 2019-12-11 00:00:00 发表: 诺贝尔的影响力让这个期刊又复活了, beContent=无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6335323471, createdName=148b3210m02暂无昵称, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887354, encodeId=aa3e88e354c9, content=额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Tue Sep 22 14:21:23 CST 2020, time=2020-09-22, status=1, ipAttribution=)]

2025-05-22 ms4000001252060402 来自广东省

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：肿瘤科
经验分享：还有朋友是一样的吗，杂志接受了，支付了版面费，然后又被拒稿，而且没有明确原因拒稿，联系方式微：FFFWW101

16 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2266161, encodeId=80bb226616106, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤科 经验分享：还有朋友是一样的吗，杂志接受了，支付了版面费，然后又被拒稿，而且没有明确原因拒稿，联系方式微：FFFWW101 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a59736045, createdName=ms4000001252060402, createdTime=Thu May 22 11:05:58 CST 2025, time=2025-05-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1214905, encodeId=b7c812149054d, content=这本不是已经被踢了？怎么还有****, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue Apr 26 23:15:23 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580262, encodeId=e88358026202, content=有钱的医院营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, beContent=营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801382, encodeId=0ed1801382ca, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：医学综合期刊 经验分享：再想起死复生基本不可能了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 21:57:40 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010960, encodeId=44fc1010960d8, content=偏重的研究方向：肿瘤 经验分享：2021年的文章都被pubmed收录了，我估计离复活不远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c06b1686709, createdName=飞翔的蜗牛, createdTime=Tue Aug 24 14:41:39 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105116, encodeId=26a611051165b, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105115, encodeId=dee31105115ae, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051245, encodeId=6487105124531, content=我感觉文章质量比同为水刊的plos one差太多了，尤其是最近几期太烂了。我认为回归的可能不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Tue Sep 14 19:59:27 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590707, encodeId=eca0590e0725, content=您好，不知道近期是否有晋升发表文章的需求？公司完稿文章论著数篇，无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了无奈的科研者 2019-12-11 00:00:00 发表: 诺贝尔的影响力让这个期刊又复活了, beContent=无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6335323471, createdName=148b3210m02暂无昵称, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887354, encodeId=aa3e88e354c9, content=额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Tue Sep 22 14:21:23 CST 2020, time=2020-09-22, status=1, ipAttribution=)]

2022-04-26 ms7000000507856696

这本不是已经被踢了？怎么还有****

152 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2266161, encodeId=80bb226616106, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤科 经验分享：还有朋友是一样的吗，杂志接受了，支付了版面费，然后又被拒稿，而且没有明确原因拒稿，联系方式微：FFFWW101 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a59736045, createdName=ms4000001252060402, createdTime=Thu May 22 11:05:58 CST 2025, time=2025-05-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1214905, encodeId=b7c812149054d, content=这本不是已经被踢了？怎么还有****, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue Apr 26 23:15:23 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580262, encodeId=e88358026202, content=有钱的医院营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, beContent=营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801382, encodeId=0ed1801382ca, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：医学综合期刊 经验分享：再想起死复生基本不可能了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 21:57:40 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010960, encodeId=44fc1010960d8, content=偏重的研究方向：肿瘤 经验分享：2021年的文章都被pubmed收录了，我估计离复活不远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c06b1686709, createdName=飞翔的蜗牛, createdTime=Tue Aug 24 14:41:39 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105116, encodeId=26a611051165b, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105115, encodeId=dee31105115ae, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051245, encodeId=6487105124531, content=我感觉文章质量比同为水刊的plos one差太多了，尤其是最近几期太烂了。我认为回归的可能不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Tue Sep 14 19:59:27 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590707, encodeId=eca0590e0725, content=您好，不知道近期是否有晋升发表文章的需求？公司完稿文章论著数篇，无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了无奈的科研者 2019-12-11 00:00:00 发表: 诺贝尔的影响力让这个期刊又复活了, beContent=无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6335323471, createdName=148b3210m02暂无昵称, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887354, encodeId=aa3e88e354c9, content=额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Tue Sep 22 14:21:23 CST 2020, time=2020-09-22, status=1, ipAttribution=)]

2019-11-22 emilia77

有钱的医院营养医师 2019-11-20 00:00:00 发表:
去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。

营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。

262 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2266161, encodeId=80bb226616106, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤科 经验分享：还有朋友是一样的吗，杂志接受了，支付了版面费，然后又被拒稿，而且没有明确原因拒稿，联系方式微：FFFWW101 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a59736045, createdName=ms4000001252060402, createdTime=Thu May 22 11:05:58 CST 2025, time=2025-05-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1214905, encodeId=b7c812149054d, content=这本不是已经被踢了？怎么还有****, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue Apr 26 23:15:23 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580262, encodeId=e88358026202, content=有钱的医院营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, beContent=营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801382, encodeId=0ed1801382ca, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：医学综合期刊 经验分享：再想起死复生基本不可能了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 21:57:40 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010960, encodeId=44fc1010960d8, content=偏重的研究方向：肿瘤 经验分享：2021年的文章都被pubmed收录了，我估计离复活不远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c06b1686709, createdName=飞翔的蜗牛, createdTime=Tue Aug 24 14:41:39 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105116, encodeId=26a611051165b, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105115, encodeId=dee31105115ae, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051245, encodeId=6487105124531, content=我感觉文章质量比同为水刊的plos one差太多了，尤其是最近几期太烂了。我认为回归的可能不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Tue Sep 14 19:59:27 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590707, encodeId=eca0590e0725, content=您好，不知道近期是否有晋升发表文章的需求？公司完稿文章论著数篇，无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了无奈的科研者 2019-12-11 00:00:00 发表: 诺贝尔的影响力让这个期刊又复活了, beContent=无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6335323471, createdName=148b3210m02暂无昵称, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887354, encodeId=aa3e88e354c9, content=额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Tue Sep 22 14:21:23 CST 2020, time=2020-09-22, status=1, ipAttribution=)]

2020-07-05 扫地医生

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：医学综合期刊
经验分享：再想起死复生基本不可能了

333 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2266161, encodeId=80bb226616106, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤科 经验分享：还有朋友是一样的吗，杂志接受了，支付了版面费，然后又被拒稿，而且没有明确原因拒稿，联系方式微：FFFWW101 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a59736045, createdName=ms4000001252060402, createdTime=Thu May 22 11:05:58 CST 2025, time=2025-05-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1214905, encodeId=b7c812149054d, content=这本不是已经被踢了？怎么还有****, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue Apr 26 23:15:23 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580262, encodeId=e88358026202, content=有钱的医院营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, beContent=营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801382, encodeId=0ed1801382ca, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：医学综合期刊 经验分享：再想起死复生基本不可能了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 21:57:40 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010960, encodeId=44fc1010960d8, content=偏重的研究方向：肿瘤 经验分享：2021年的文章都被pubmed收录了，我估计离复活不远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c06b1686709, createdName=飞翔的蜗牛, createdTime=Tue Aug 24 14:41:39 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105116, encodeId=26a611051165b, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105115, encodeId=dee31105115ae, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051245, encodeId=6487105124531, content=我感觉文章质量比同为水刊的plos one差太多了，尤其是最近几期太烂了。我认为回归的可能不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Tue Sep 14 19:59:27 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590707, encodeId=eca0590e0725, content=您好，不知道近期是否有晋升发表文章的需求？公司完稿文章论著数篇，无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了无奈的科研者 2019-12-11 00:00:00 发表: 诺贝尔的影响力让这个期刊又复活了, beContent=无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6335323471, createdName=148b3210m02暂无昵称, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887354, encodeId=aa3e88e354c9, content=额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Tue Sep 22 14:21:23 CST 2020, time=2020-09-22, status=1, ipAttribution=)]

2021-08-24 飞翔的蜗牛

偏重的研究方向：肿瘤
经验分享：2021年的文章都被pubmed收录了，我估计离复活不远了

196 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2266161, encodeId=80bb226616106, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤科 经验分享：还有朋友是一样的吗，杂志接受了，支付了版面费，然后又被拒稿，而且没有明确原因拒稿，联系方式微：FFFWW101 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a59736045, createdName=ms4000001252060402, createdTime=Thu May 22 11:05:58 CST 2025, time=2025-05-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1214905, encodeId=b7c812149054d, content=这本不是已经被踢了？怎么还有****, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue Apr 26 23:15:23 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580262, encodeId=e88358026202, content=有钱的医院营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, beContent=营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801382, encodeId=0ed1801382ca, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：医学综合期刊 经验分享：再想起死复生基本不可能了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 21:57:40 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010960, encodeId=44fc1010960d8, content=偏重的研究方向：肿瘤 经验分享：2021年的文章都被pubmed收录了，我估计离复活不远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c06b1686709, createdName=飞翔的蜗牛, createdTime=Tue Aug 24 14:41:39 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105116, encodeId=26a611051165b, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105115, encodeId=dee31105115ae, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051245, encodeId=6487105124531, content=我感觉文章质量比同为水刊的plos one差太多了，尤其是最近几期太烂了。我认为回归的可能不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Tue Sep 14 19:59:27 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590707, encodeId=eca0590e0725, content=您好，不知道近期是否有晋升发表文章的需求？公司完稿文章论著数篇，无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了无奈的科研者 2019-12-11 00:00:00 发表: 诺贝尔的影响力让这个期刊又复活了, beContent=无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6335323471, createdName=148b3210m02暂无昵称, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887354, encodeId=aa3e88e354c9, content=额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Tue Sep 22 14:21:23 CST 2020, time=2020-09-22, status=1, ipAttribution=)]

2021-12-29 MS54455111222

老牌期刊和新出版期刊是否都要选一些？

163 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2266161, encodeId=80bb226616106, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤科 经验分享：还有朋友是一样的吗，杂志接受了，支付了版面费，然后又被拒稿，而且没有明确原因拒稿，联系方式微：FFFWW101 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a59736045, createdName=ms4000001252060402, createdTime=Thu May 22 11:05:58 CST 2025, time=2025-05-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1214905, encodeId=b7c812149054d, content=这本不是已经被踢了？怎么还有****, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue Apr 26 23:15:23 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580262, encodeId=e88358026202, content=有钱的医院营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, beContent=营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801382, encodeId=0ed1801382ca, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：医学综合期刊 经验分享：再想起死复生基本不可能了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 21:57:40 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010960, encodeId=44fc1010960d8, content=偏重的研究方向：肿瘤 经验分享：2021年的文章都被pubmed收录了，我估计离复活不远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c06b1686709, createdName=飞翔的蜗牛, createdTime=Tue Aug 24 14:41:39 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105116, encodeId=26a611051165b, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105115, encodeId=dee31105115ae, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051245, encodeId=6487105124531, content=我感觉文章质量比同为水刊的plos one差太多了，尤其是最近几期太烂了。我认为回归的可能不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Tue Sep 14 19:59:27 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590707, encodeId=eca0590e0725, content=您好，不知道近期是否有晋升发表文章的需求？公司完稿文章论著数篇，无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了无奈的科研者 2019-12-11 00:00:00 发表: 诺贝尔的影响力让这个期刊又复活了, beContent=无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6335323471, createdName=148b3210m02暂无昵称, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887354, encodeId=aa3e88e354c9, content=额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Tue Sep 22 14:21:23 CST 2020, time=2020-09-22, status=1, ipAttribution=)]

2021-12-27 桑晒麦拉

除文章内容和质量外，选刊时还需注意什么？

153 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2266161, encodeId=80bb226616106, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤科 经验分享：还有朋友是一样的吗，杂志接受了，支付了版面费，然后又被拒稿，而且没有明确原因拒稿，联系方式微：FFFWW101 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a59736045, createdName=ms4000001252060402, createdTime=Thu May 22 11:05:58 CST 2025, time=2025-05-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1214905, encodeId=b7c812149054d, content=这本不是已经被踢了？怎么还有****, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue Apr 26 23:15:23 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580262, encodeId=e88358026202, content=有钱的医院营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, beContent=营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801382, encodeId=0ed1801382ca, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：医学综合期刊 经验分享：再想起死复生基本不可能了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 21:57:40 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010960, encodeId=44fc1010960d8, content=偏重的研究方向：肿瘤 经验分享：2021年的文章都被pubmed收录了，我估计离复活不远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c06b1686709, createdName=飞翔的蜗牛, createdTime=Tue Aug 24 14:41:39 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105116, encodeId=26a611051165b, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105115, encodeId=dee31105115ae, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051245, encodeId=6487105124531, content=我感觉文章质量比同为水刊的plos one差太多了，尤其是最近几期太烂了。我认为回归的可能不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Tue Sep 14 19:59:27 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590707, encodeId=eca0590e0725, content=您好，不知道近期是否有晋升发表文章的需求？公司完稿文章论著数篇，无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了无奈的科研者 2019-12-11 00:00:00 发表: 诺贝尔的影响力让这个期刊又复活了, beContent=无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6335323471, createdName=148b3210m02暂无昵称, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887354, encodeId=aa3e88e354c9, content=额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Tue Sep 22 14:21:23 CST 2020, time=2020-09-22, status=1, ipAttribution=)]

2021-09-14 张晓梅-Xiaomei Zhang

我感觉文章质量比同为水刊的plos one差太多了，尤其是最近几期太烂了。我认为回归的可能不大

0 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2266161, encodeId=80bb226616106, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤科 经验分享：还有朋友是一样的吗，杂志接受了，支付了版面费，然后又被拒稿，而且没有明确原因拒稿，联系方式微：FFFWW101 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a59736045, createdName=ms4000001252060402, createdTime=Thu May 22 11:05:58 CST 2025, time=2025-05-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1214905, encodeId=b7c812149054d, content=这本不是已经被踢了？怎么还有****, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue Apr 26 23:15:23 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580262, encodeId=e88358026202, content=有钱的医院营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, beContent=营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801382, encodeId=0ed1801382ca, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：医学综合期刊 经验分享：再想起死复生基本不可能了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 21:57:40 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010960, encodeId=44fc1010960d8, content=偏重的研究方向：肿瘤 经验分享：2021年的文章都被pubmed收录了，我估计离复活不远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c06b1686709, createdName=飞翔的蜗牛, createdTime=Tue Aug 24 14:41:39 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105116, encodeId=26a611051165b, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105115, encodeId=dee31105115ae, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051245, encodeId=6487105124531, content=我感觉文章质量比同为水刊的plos one差太多了，尤其是最近几期太烂了。我认为回归的可能不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Tue Sep 14 19:59:27 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590707, encodeId=eca0590e0725, content=您好，不知道近期是否有晋升发表文章的需求？公司完稿文章论著数篇，无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了无奈的科研者 2019-12-11 00:00:00 发表: 诺贝尔的影响力让这个期刊又复活了, beContent=无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6335323471, createdName=148b3210m02暂无昵称, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887354, encodeId=aa3e88e354c9, content=额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Tue Sep 22 14:21:23 CST 2020, time=2020-09-22, status=1, ipAttribution=)]

2020-05-12 148b3210m02暂无昵称

您好，不知道近期是否有晋升发表文章的需求？公司完稿文章论著数篇，无奈的科研者 2019-12-11 发表::
诺贝尔的影响力让这个期刊又复活了无奈的科研者 2019-12-11 00:00:00 发表:
诺贝尔的影响力让这个期刊又复活了

无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了

303 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2266161, encodeId=80bb226616106, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤科 经验分享：还有朋友是一样的吗，杂志接受了，支付了版面费，然后又被拒稿，而且没有明确原因拒稿，联系方式微：FFFWW101 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a59736045, createdName=ms4000001252060402, createdTime=Thu May 22 11:05:58 CST 2025, time=2025-05-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1214905, encodeId=b7c812149054d, content=这本不是已经被踢了？怎么还有****, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue Apr 26 23:15:23 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580262, encodeId=e88358026202, content=有钱的医院营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, beContent=营养医师 2019-11-20 00:00:00 发表: 去年我们医院有个人发了两篇oncotarget，奖励了十几万。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1eb41658470, createdName=emilia77, createdTime=Fri Nov 22 00:00:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801382, encodeId=0ed1801382ca, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：医学综合期刊 经验分享：再想起死复生基本不可能了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 21:57:40 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010960, encodeId=44fc1010960d8, content=偏重的研究方向：肿瘤 经验分享：2021年的文章都被pubmed收录了，我估计离复活不远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c06b1686709, createdName=飞翔的蜗牛, createdTime=Tue Aug 24 14:41:39 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105116, encodeId=26a611051165b, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105115, encodeId=dee31105115ae, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051245, encodeId=6487105124531, content=我感觉文章质量比同为水刊的plos one差太多了，尤其是最近几期太烂了。我认为回归的可能不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Tue Sep 14 19:59:27 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590707, encodeId=eca0590e0725, content=您好，不知道近期是否有晋升发表文章的需求？公司完稿文章论著数篇，无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了无奈的科研者 2019-12-11 00:00:00 发表: 诺贝尔的影响力让这个期刊又复活了, beContent=无奈的科研者 2019-12-11 发表:: 诺贝尔的影响力让这个期刊又复活了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6335323471, createdName=148b3210m02暂无昵称, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887354, encodeId=aa3e88e354c9, content=额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Tue Sep 22 14:21:23 CST 2020, time=2020-09-22, status=1, ipAttribution=)]

2020-09-22 飞翔的乌龟

额

262 1 举报

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务